New test could sharply reduce risky, costly lung cancer biopsies

Washington PostNew test could sharply reduce risky, costly lung cancer biopsiesWashington PostOther research is being conducted to find markers for lung cancer, though much of it focuses on substances that can be found in the blood, Spira said. With the vast majority of lung cancer victims being smokers, the epithelial cells show changes that ...Veracyte lung cancer test could help avoid some risky biopsiesReutersPublic Release: 17-May-2015 Study validates effectiveness of genomic test for ...EurekAlert (press release)all 4 news articles »

Share this post